Effect of COVID-19 Lockdowns on Eye Emergency Department, Increasing Prevalence of Uveitis and Optic Neuritis in the COVID-19 Era
Overview
Authors
Affiliations
Background: The COVID-19 pandemic led to the reorganization of the health care system. A decline in health- and life-saving procedures has been reported in various medical specialties. However, data on ophthalmic emergencies during lockdowns is limited. Methods: We conducted a retrospective, observational, case-control study of 2351 patients registered at the ophthalmic emergency department of a tertiary hospital in Poland during three national COVID-19 lockdowns (March/April 2020, November 2020, and March/April 2021) and corresponding months in 2019. Results: The total number of visits declined from a mean of 720/month in the non-COVID era to 304/month during COVID-19 lockdowns (p < 0.001). Ocular trauma incidence dropped significantly from 2019 (non-COVID months) to 2020/2021 (COVID group mean 201 vs. 97 patients monthly, respectively, p = 0.03). Of note, the percentage of foreign bodies removal was significantly higher during lockdowns than corresponding time in the non-COVID era. A downward trend for vitreous detachment and macular disorders cases was observed between COVID and non-COVID time. Uveitis and optic neuritis patients were seen more often during lockdowns (p < 0.001 and p = 0.0013, respectively). In contrast, the frequency of conjunctivitis and keratitis, potentially COVID-related problems, decreased significantly in COVID-19 time (mean 138 vs. 23 per month in non-COVID vs. COVID lockdowns, respectively, p < 0.001). Conclusions: The overall number of eye emergency visits declined during COVID-19 lockdowns. Conjunctivitis and keratitis rates dropped during the lockdowns. Interestingly, the frequency of immune-mediated ocular conditions (uveitis, optic neuritis) increased significantly which might be triggered by SARS-CoV2 infection.
Bibliometric analysis of published works in ocular trauma: a growing focus on open globe injury.
Choudhry H, Kuklinski E, Fu A, Shukla P, Montani M, Eraky F Int Ophthalmol. 2025; 45(1):47.
PMID: 39881069 DOI: 10.1007/s10792-025-03417-5.
Cao C, Li Q, Cai D, Yue C, Zhao H Front Immunol. 2024; 15:1440262.
PMID: 39081310 PMC: 11286426. DOI: 10.3389/fimmu.2024.1440262.
A review of neuro-ophthalmic sequelae following COVID-19 infection and vaccination.
Shi J, Danesh-Meyer H Front Cell Infect Microbiol. 2024; 14:1345683.
PMID: 38299114 PMC: 10827868. DOI: 10.3389/fcimb.2024.1345683.
New onset or recurrence of uveitis following COVID-19 infection.
Feng H, Zhao M, Mo J, Cao X, Chen W, Wang H BMC Ophthalmol. 2024; 24(1):23.
PMID: 38233844 PMC: 10792851. DOI: 10.1186/s12886-024-03289-w.